Philip Rosenthal, MD, and a panel of leading malaria experts drawn from
academia, the military, and international health organizations survey
the latest scientific understanding of antimalarial chemotherapy,
emphasizing the molecular mechanisms of resistance and the description
of important new targets. Their survey covers the current status of
malarial and antimalarial chemotherapy, the relevant biology and
biochemistry of malaria parasites, the antimalarial drugs currently
available, new chemical approaches to chemotherapy, and possible new
targets for chemotherapy. Comprehensive and cutting-edge, Antimalarial
Chemotherapy: Mechanisms of Action, Resistance, and New Directions in
Drug Discovery clearly delineates all the basic and clinical research
now addressing one of the world's major unresolved disease problems,
work that is now powerfully driving the rapid pace of antimalarial drug
discovery today.